Antibodies to the hemagglutinin (HA) and neuraminidase (NA) glycoproteins are the major
mediators of protection against influenza virus infection. Here, we report that current influenza …

Bats are reservoir hosts for many zoonotic viruses. Despite this, relatively little is known about
the diversity and abundance of viruses within individual bats, and hence the frequency of …

Influenza is a leading cause of death in the elderly, and the vaccine protects only a fraction
of this population. A key aspect of antibody-mediated anti-influenza virus immunity is …

Humans are repeatedly exposed to variants of influenza virus throughout their lifetime. As a
result, preexisting influenza-specific memory B cells can dominate the response after …

Increasing evidence suggests that dysregulated immune responses are associated with the
clinical outcome of coronavirus disease 2019 (COVID-19). Nucleocapsid protein (NP)-, …

Background Influenza viruses cause substantial annual morbidity and mortality globally.
Current vaccines protect against influenza only when well matched to the circulating strains. …

Although human antibodies elicited by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) nucleocapsid (N) protein are profoundly boosted upon infection, little is …

B cell response plays a critical role against SARS-CoV-2 infection. However, little is known
about the diversity and frequency of the paired SARS-CoV-2 antigen-specific BCR repertoire …

Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct antigens
and is a common feature of antibodies induced upon pathogen exposure. However, little is …

The rapid mutation and spread of SARS-CoV-2 variants urge the development of effective
mucosal vaccines to provide broad-spectrum protection against the initial infection and …